Share
Market Research Report

DIABETES DIAGNOSTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Product TypeBlood Glucose Meters · Continuous Glucose Monitoring (CGM) Systems · Testing Strips · Lancets and Lancing Devices · HbA1c Testing Kits · Ketone Testing Kits · Insulin Dose Calculators/Insulin Delivery Devices · and Others (e.g., smart wearables, emerging digital diagnostic tools)
  • By Testing TypeSelf-Monitoring Blood Glucose (SMBG) Tests · Laboratory-Based Tests · and Point-of-Care (POC) Tests
  • By Diagnostic TechnologyElectrochemical Biosensors · Optical Sensors · Enzymatic Assays · Immunoassays · Microfluidic Technology · and Others (e.g., next-gen nanotechnology-based diagnostics)
  • By Diabetes TypeType 1 Diabetes · Type 2 Diabetes · Gestational Diabetes · and Prediabetes/Screening
  • By End UserHospitals and Clinics · Diagnostic Laboratories · Home Care Settings · Ambulator · By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
  • Published In10 Mar 2026
  • Report CodeCMI8524
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Market Segmentation

  • Product Type Insights (Revenue, USD Bn, 2021 - 2033)

    • Blood Glucose Meters
    • Continuous Glucose Monitoring (CGM) Systems
    • Testing Strips
    • Lancets and Lancing Devices
    • HbA1c Testing Kits
    • Ketone Testing Kits
    • Insulin Dose Calculators/Insulin Delivery Devices
    • Others (e.g., smart wearables, emerging digital diagnostic tools)
  • Testing Type Insights (Revenue, USD Bn, 2021 - 2033)

    • Self-Monitoring Blood Glucose (SMBG) Tests
    • Laboratory-Based Tests
    • Point-of-Care (POC) Tests
  • Diagnostic Technology Insights (Revenue, USD Bn, 2021 - 2033)

    • Electrochemical Biosensors
    • Optical Sensors
    • Enzymatic Assays
    • Immunoassays
    • Microfluidic Technology
    • Others (e.g., next-gen nanotechnology-based diagnostics)
  • Diabetes Type Insights (Revenue, USD Bn, 2021 - 2033)

    • Type 1 Diabetes
    • Type 2 Diabetes
    • Gestational Diabetes
    • Prediabetes/Screening
  • End User Insights (Revenue, USD Bn, 2021 - 2033)

    • Hospitals and Clinics
    • Diagnostic Laboratories
    • Home Care Settings
    • Ambulatory Surgical Centers (ASCs)
    • Others (Research Institutes and Academic Centers)
  • Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa